DMTTF - Moving Closer To Cybin Acquisition Small Pharma Obtains Final Order Approving Arrangement | Benzinga
Short-acting psychedelics biotech Small Pharma Inc. (OTCQB: DMTTF) has obtained a final order from the Supreme Court of British Columbia approving the announced plan of arrangement, under Division 5 of Part 9 of BC’s Business Corporations Act, by which clinical-stage biotech firm Cybin Inc. (NYSE: CYBN) is set to acquire all the former’s issued and outstanding securities in an all-share transaction.
With this approval and ...